Since the human genome project was completed in 2003, we have witnessed a tremendous technological development. DNA sequencing is today 100 million times more efficient than 10 years ago, and the price for sequencing a human genome has fallen to below 1000 USD. This has made it possible to perform experiments that we could only dream of a few years ago. Today the main challenge is to make sense of the vast amount of data we gather from cells, tissues and patients. We use these data to improve our understanding of biology and pathophysiology and to make better clinical decisions for patients.
Participants: David Botstein, Princeton University, Anne-Lise Børresen-Dale, UiO, Tom Hemming Karlsen, UiO and OUS and Dag Undlien, UiO.
Time and place: Sep 12, 2014 10:00 AM - 12:00 PM, Radiumhospitalet, Auditorium, Research building.
10.00-10.40: David Botstein: System-level analysis of metabolic pathways in yeast
10.45-11.10: Tom Hemming Karlsen: GWAS in liver and bowel diseases - what have been achieved?
11.10.-11.35: Dag Undlien: Genomics in monogenic disorders – from bench to bedside
11.35-12.00: Anne-Lise Børresen-Dale: What can we learn from Pan-Cancer Genomics
Professor Anne Lise Børresen-Dale and Professor Dag Undlien